Lista de obras -

A novel TTN deletion in a family with skeletal myopathy, facial weakness, and dilated cardiomyopathy

scientific article published on 05 September 2019

A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia

artículo científico publicado en 2015

Acute decompensated heart failure: update on new and emerging evidence and directions for future research

artículo científico publicado en 2013

Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee

article by James C Fang et al published 4 May 2015 in Journal of Cardiac Failure

Cardiovascular genetic medicine: evolving concepts, rationale, and implementation.

artículo científico publicado en 2008

ClinGen Variant Curation Expert Panel experiences and standardized processes for disease and gene-level specification of the ACMG/AMP guidelines for sequence variant interpretation

article

Clinical Application of Genetic Testing in Heart Failure.

artículo científico publicado en 2017

Clinical Genetic Testing for Familial Hypercholesterolemia

artículo científico publicado en 2018

Clinical Outcomes, Quality of Life, and Cost Outcomes After Cardiac Transplantation

artículo científico publicado el 1 de septiembre de 1997

Clinical and genetic issues in dilated cardiomyopathy: A review for genetics professionals ⬇️

artículo científico publicado el 1 de noviembre de 2010

Considering complexity in the genetic evaluation of dilated cardiomyopathy

artículo científico publicado en 2020

Dilated cardiomyopathy

scientific article published on 09 May 2019

Dilated cardiomyopathy: the complexity of a diverse genetic architecture.

artículo científico

Dopaminergic inhibition of DNA synthesis in pituitary tumor cells is associated with phosphotyrosine phosphatase activity ⬇️

artículo científico publicado el 5 de diciembre de 1992

Dual percutaneous mechanical circulatory support as a bridge to recovery in fulminant myocarditis

artículo científico publicado en 2011

Effect of therapeutic dopamine administration on myocardial catecholamine and neuropeptide Y concentrations in the failing ventricles of patients with idiopathic dilated cardiomyopathy

artículo científico publicado el 1 de enero de 1992

Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes

article

Evidence-Based Assessment of Genes in Dilated Cardiomyopathy

artículo científico publicado en 2021

Extracellular signal-regulated protein kinase activation is required for the anti-hypertrophic effect of atrial natriuretic factor in neonatal rat ventricular myocytes

scientific article published in 1999

Functional characterization of TNNC1 rare variants identified in dilated cardiomyopathy.

artículo científico publicado en 2011

Genetic Counseling and Screening Issues in Familial Dilated Cardiomyopathy

artículo científico publicado en 2001

Genetic Evaluation of Cardiomyopathy - a Heart Failure Society of America Practice Guideline.

artículo científico publicado en 2018

Genetic cardiomyopathies.

artículo científico publicado en 2018

Genetic testing in cardiovascular medicine: current landscape and future horizons.

artículo científico

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

artículo científico

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

artículo científico publicado en 2011

Harmonizing the Collection of Clinical Data on Genetic Testing Requisition Forms to Enhance Variant Interpretation in Hypertrophic Cardiomyopathy (HCM)

artículo científico publicado en 2021

Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy.

artículo científico publicado en 2010

Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee

artículo científico publicado en 2012

Is Left Ventricular Noncompaction a Trait, Phenotype, or Disease? The Evidence Points to Phenotype

artículo científico publicado en 2017

Late infection in cardiac allograft recipients: profiles, incidence, and outcome

artículo científico publicado el 1 de mayo de 1991

Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors ⬇️

artículo científico publicado el 1 de agosto de 1991

Mechanism of Action of Bucindolol in Human Ventricular Myocardium ⬇️

artículo científico publicado el 1 de junio de 1990

Multigenic Disease and Bilineal Inheritance in Dilated Cardiomyopathy Is Illustrated in Nonsegregating LMNA Pedigrees

artículo científico publicado en 2018

Novel familial dilated cardiomyopathy mutation in MYL2 affects the structure and function of myosin regulatory light chain

artículo científico publicado en 2015

Pilot Randomized Controlled Trial to Reduce Readmission for Heart Failure Using Novel Tablet and Nurse Practitioner Education.

artículo científico publicado en 2018

Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy.

artículo científico publicado en 2009

Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy

artículo científico publicado el 1 de mayo de 1992

Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy.

artículo científico publicado en 2010

Reappraisal of Reported Genes for Sudden Arrhythmic Death: An Evidence-Based Evaluation of Gene Validity for Brugada Syndrome

article

Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids

artículo científico publicado el 1 de marzo de 1992

Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy

scientific article published on 01 March 2019

Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute.

artículo científico publicado en 2010

Return of genetic results in the familial dilated cardiomyopathy research project

scientific article published on 11 August 2012

SCN5A Rare Variants in Familial Dilated Cardiomyopathy Decrease Peak Sodium Current Depending on the Common Polymorphism H558R and Common Splice Variant Q1077del ⬇️

artículo científico publicado el 1 de diciembre de 2010

Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy.

artículo científico publicado en 2013

The Rationale and Timing of Molecular Genetic Testing for Dilated Cardiomyopathy

artículo científico publicado en 2015

Toward Genetics-Driven Early Intervention in Dilated Cardiomyopathy: Design and Implementation of the DCM Precision Medicine Study.

artículo científico publicado en 2017

Update on Aldosterone Antagonists Use in Heart Failure With Reduced Left Ventricular Ejection Fraction Heart Failure Society of America Guidelines Committee

artículo científico publicado en 2012

Variants of Uncertain Significance: Should We Revisit How They Are Evaluated and Disclosed?

artículo científico publicado en 2018

Vasoactive intestinal peptide in canine hearts: effect of total cardiac denervation

artículo científico publicado el 1 de febrero de 1992

Where genome meets phenome: rationale for integrating genetic and protein biomarkers in the diagnosis and management of dilated cardiomyopathy and heart failure.

artículo científico

Lista de obras de

A novel TTN deletion in a family with skeletal myopathy, facial weakness, and dilated cardiomyopathy

A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia

Acute decompensated heart failure: update on new and emerging evidence and directions for future research

Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee

Cardiovascular genetic medicine: evolving concepts, rationale, and implementation.

ClinGen Variant Curation Expert Panel experiences and standardized processes for disease and gene-level specification of the ACMG/AMP guidelines for sequence variant interpretation

Clinical Application of Genetic Testing in Heart Failure.

Clinical Genetic Testing for Familial Hypercholesterolemia

Clinical Outcomes, Quality of Life, and Cost Outcomes After Cardiac Transplantation

Clinical and genetic issues in dilated cardiomyopathy: A review for genetics professionals ⬇️

Considering complexity in the genetic evaluation of dilated cardiomyopathy

Dilated cardiomyopathy

Dilated cardiomyopathy: the complexity of a diverse genetic architecture.

Dopaminergic inhibition of DNA synthesis in pituitary tumor cells is associated with phosphotyrosine phosphatase activity ⬇️

Dual percutaneous mechanical circulatory support as a bridge to recovery in fulminant myocarditis

Effect of therapeutic dopamine administration on myocardial catecholamine and neuropeptide Y concentrations in the failing ventricles of patients with idiopathic dilated cardiomyopathy

Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes

Evidence-Based Assessment of Genes in Dilated Cardiomyopathy

Extracellular signal-regulated protein kinase activation is required for the anti-hypertrophic effect of atrial natriuretic factor in neonatal rat ventricular myocytes

Functional characterization of TNNC1 rare variants identified in dilated cardiomyopathy.

Genetic Counseling and Screening Issues in Familial Dilated Cardiomyopathy

Genetic Evaluation of Cardiomyopathy - a Heart Failure Society of America Practice Guideline.

Genetic cardiomyopathies.

Genetic testing in cardiovascular medicine: current landscape and future horizons.

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

Harmonizing the Collection of Clinical Data on Genetic Testing Requisition Forms to Enhance Variant Interpretation in Hypertrophic Cardiomyopathy (HCM)

Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy.

Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee

Is Left Ventricular Noncompaction a Trait, Phenotype, or Disease? The Evidence Points to Phenotype

Late infection in cardiac allograft recipients: profiles, incidence, and outcome

Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors ⬇️

Mechanism of Action of Bucindolol in Human Ventricular Myocardium ⬇️

Multigenic Disease and Bilineal Inheritance in Dilated Cardiomyopathy Is Illustrated in Nonsegregating LMNA Pedigrees

Novel familial dilated cardiomyopathy mutation in MYL2 affects the structure and function of myosin regulatory light chain

Pilot Randomized Controlled Trial to Reduce Readmission for Heart Failure Using Novel Tablet and Nurse Practitioner Education.

Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy

Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy.

Reappraisal of Reported Genes for Sudden Arrhythmic Death: An Evidence-Based Evaluation of Gene Validity for Brugada Syndrome

Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids

Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy

Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute.

Return of genetic results in the familial dilated cardiomyopathy research project

SCN5A Rare Variants in Familial Dilated Cardiomyopathy Decrease Peak Sodium Current Depending on the Common Polymorphism H558R and Common Splice Variant Q1077del ⬇️

Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy.

The Rationale and Timing of Molecular Genetic Testing for Dilated Cardiomyopathy

Toward Genetics-Driven Early Intervention in Dilated Cardiomyopathy: Design and Implementation of the DCM Precision Medicine Study.

Update on Aldosterone Antagonists Use in Heart Failure With Reduced Left Ventricular Ejection Fraction Heart Failure Society of America Guidelines Committee

Variants of Uncertain Significance: Should We Revisit How They Are Evaluated and Disclosed?

Vasoactive intestinal peptide in canine hearts: effect of total cardiac denervation

Where genome meets phenome: rationale for integrating genetic and protein biomarkers in the diagnosis and management of dilated cardiomyopathy and heart failure.